We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




German-Israeli Center for Brain Research Dedicated in Recent Ceremony

By LabMedica International staff writers
Posted on 21 Jan 2013
A new center for collaborative brain research between German and Israeli scientists was dedicated in a ceremony held recently in Jerusalem.

The new center, called the Max Planck-Hebrew University Center for Sensory Processing of the Brain in Action, will be staffed by researchers from the Max Planck Institute of Neurobiology (Martinsried, Germany) and the Edmond and Lily Safra Center for Brain Sciences at the Hebrew University of Jerusalem (Israel).

The new center, which is to be housed at the Hebrew University of Jerusalem, will be funded at three million euros for its first five years. More...
It is one of only nine such international partnerships between the Max Planck Society and a foreign research institution and is the only one in the field of brain research.

Researchers from the two institutions will be studying both individual nerve cells as well as circuits of cells and analyzing how sensory perceptions are processed in the brain. These topics mesh well with the Hebrew University's interdisciplinary approach that includes neuroscientists, physicists, computer scientists, cognitive scientists, and others who focus on several broad areas of inquiry, including genes and neurons, neural networks learning and plasticity, cognitive neuroscience, computational neuroscience, and sensory and motor functions.

Special emphasis will be placed on recruiting young Israeli and German investigators through fellowships and joint research programs.

“The center raises our long-standing partnership in the field of neuroscience to a new level of quality. It offers the prospect of an entirely new dimension in the study of the brain in particular,” said Dr. Peter Gruss, the president of the Max Planck Society.

President of the Hebrew University of Jerusalem Dr. Menahem Ben-Sasson, said, “Cooperation with Germany in science and research is among the most important and fruitful of our international contacts, and makes it possible for us to be at the forefront of science. We are happy to be one of the first universities in the world outside of Germany in which a joint research center is being established with the Max Planck Society, and look forward to further cooperation in the future.”

Related Links:

Max Planck Institute of Neurobiology
Hebrew University of Jerusalem



Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
Hematology Consumables
Bioblood Devices
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.